WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8 million
October 1, 2025
WallachBeth Capital LLC, a well-known firm that focuses on capital markets and institutional trading, shared that bioAffinity Technologies, Inc., a biotech company working on noninvasive